Isolate or deplete human CD4+ T cells directly from whole blood, buffy coat or MNC with Dynabeads® CD4. For rapid and consistent results in protein or gene expression analysis, lyse the CD4+ T cells while they are still attached to the beads and directly process for further molecular analysis. For downstream cell-based applications (requiring bead-free CD4+ cells), Invitrogen Dynal® recommends the Dynabeads® FlowComp™ Human CD4 kit (cat. no. 113.61D).
Principle of Isolation
Dynabeads® are mixed with the cell sample in a tube. The Dynabeads® will bind to the target cells during a short incubation, and then the bead-bound cells are separated by a magnet.
- Positive isolation – discard the supernatant and use the bead-bound cells for downstream molecular applications.
- Depletion – discard the
beadboundcells and use the remaining, untouched cells for any application.
Description of Materials
Dynabeads® CD4 are uniform, superparamagnetic polystyrene beads (4.5 μm diameter) coated with a primary monoclonal antibody specific for the CD4 membrane antigen on human cells. The primary CD4 antibody is coupled to the Dynabeads® via a secondary human IgG4 anti-mouse IgG antibody. The source of the human monoclonal antibody is free of Human Immunodeficiency Virus (HIV), Hepatitis-B Virus (HBV) and Hepatitis-C Virus (HCV).
- 5 ml Dynabeads® CD4. 4 x 108 beads/ml in phosphate buffered saline (PBS), pH 7.4, containing 0.1% bovine serum albumin (BSA) and 0.02% sodium azide (NaN3).
- This product will process up to 2 x 109cells.
Additional Materials Required
- Magnet (Dynal® MPC™): See Dynabeads® mRNA Purification Kit for mRNA Purification from Total RNA preps for magnet recommendations.
- Mixer allowing both tilting and rotation.
- Buffer 1: PBS w/0.1% BSA and 2 mM EDTA, pH 7.4.
- BSA can be replaced by human serum albumin (HSA) or Fetal Calf Serum (FCS).
- EDTA can be replaced by sodium citrate.
- PBS containing Ca2+ or Mg2+ is not recommended.
Dynabeads® Washing Procedure
Dynabeads® should be washed before use.
- Resuspend the Dynabeads® in the vial.
- Transfer the desired volume of Dynabeads® to a tube.
- Add the same volume of Buffer 1, or at least 1 ml, and mix.
- Place the tube in a magnet for 1 min and discard the supernatant.
- Remove the tube from the magnet and resuspend the washed Dynabeads® in the same volume of Buffer 1 as the initial volume of Dynabeads® (step 2).
Cells can be directly isolated from any sample such as whole blood, bone marrow, MNC or tissue digests.
Please visit Pan Mouse IgG - Depletion or Positive Isolation of Cells from Different Species and follow our QuickLinks for recommended sample preparation procedures.
Whole Blood and Buffy Coat
Most depletions and positive isolations can use whole blood and buffy coat as a starting sample. Buffy coat is 8-10 times more concentrated than whole blood with regard to number of leucocytes. For this product you have to
wash the blood/buffy coat to remove interfering soluble factors.
- Dilute the whole blood or buffy coat in Buffer 1 (1+2).
- Centrifuge at 600 x g for 10 min at 2-8°C.
- Discard the plasma fraction/upper layer. Resuspend blood to the original volume in Buffer 1 and buffy coat 1+1 in Buffer 1 before adding the beads.
Critical Steps for Cell Isolation
- Use a mixer that provides tilting and rotation of the tubes to ensure Dynabeads® do not settle at the bottom of the tube.
- When incubating Dynabeads® and cells, the incubation temperature must be 2-8°C to reduce phagocytic activity and other metabolic processes.
- Never use less than 25 μl (1 x 107) Dynabeads® per ml of cell sample and at least 4 Dynabeads® per target cell.
Table 1: Volume of Dynabeads® added per 107 cells. The volumes can be scaled up as required.
|Sample volume -||1 ml||1 ml|
|Volume of Dynabeads®||25 μl||50 μl|
|Total no. of cells|
processed per product
|2 x 109 cells||1 x 109 cells|
Depletion or Positive Isolation of CD4+ T Cells
- Add the appropriate volume of Dynabeads® to the prepared sample according to table 1.
- Incubate for 20 min (positive isolation) or 30 min (depletion) at 2 - 8°C with gentle tilting and rotation.
- Place the tube in a magnet for 2 min.
- For depletion, transfer supernatant to a new tube for further use.
- For positive isolation, discard the supernatant and wash the beadbound cells 3 times by resuspending in Buffer 1 to the original sample volume, and separate using a magnet for 1 min. Never use less than 1 ml Buffer 1 in each washing step. For molecular studies, lyse cells while still attached to the beads and transfer supernatant to a new tube for protein or gene expression analysis.
This product is stable until the expiry date stated on the label when stored unopened at 2-8°C. Store opened vials at 2-8°C and avoid bacterial contamination. Keep Dynabeads® in liquid suspension during storage and all handling steps, as drying will result in reduced performance. Resuspend well before use.
Warnings And Limitations
This product is for research use only. Not intended for any animal or human therapeutic or diagnostic use unless otherwise stated. Follow appropriate laboratory guidelines. This product contains 0.02% sodium azide as a preservative, which is cytotoxic.
Avoid pipetting by mouth!
Sodium azide may react with lead and copper plumbing to form highly explosive metal azides. When disposing through plumbing drains, flush with large volumes of water to prevent azide build up. Certificate of Analysis (CoA) is available upon request. Material Safety Data Sheet (MSDS) is available at .
- Roscic-Mrkic B et al (2003) RANTES (CCL5) uses the proteoglycan CD44 as an auxiliary receptor to mediate cellular activation signals and HIV-1 enhancement. Blood 102: 1169-1177.
- Peng Koh K et al (2004) T cell-mediated vascular dysfunction of human allografts results from IFN-g dysregulation of NO synthase. J. Clin. Investigation. 114:846-856.
- Dai KZ et al (2004) Transcriptional activation of the SH2D2A gene is dependent on a cyclic adenosine 5’- monophosphate-responsive element in the proximal SH2D2A promoter. J. Immunol. 172: 6144-6151.
For Research Use Only. Not for use in diagnostic procedures.